98%
921
2 minutes
20
Importance: The US health care sector accounts for about 8.5% of national greenhouse gas (GHG) emissions. Reliable estimates of emissions associated with health care-related travel are essential for informing policy changes.
Objective: To generate a comprehensive national estimate of carbon emissions due to patient health care-related travel in the US.
Design, Setting, And Participants: This cross-sectional study used data from the 2022 National Household Travel Survey (NHTS), conducted from January 2022 to January 2023. Participants were selected using an address-based sample from the US Postal Service Delivery Sequence File. Participating households reported all trips taken within 24 hours by all household members aged 5 years or older. Approximate emissions per mile were obtained from typical vehicle emissions data provided by US government institutions. Data were analyzed between March 11 and May 29, 2024.
Main Outcomes And Measures: Estimated annual CO2 equivalent (CO2e) emissions from patient health care-related travel per year, per patient, per trip, and per mile. A survey-weighted λ regression analysis was used to identify factors associated with higher CO2e emissions per trip. An alternative scenario analysis estimated reductions if 30% or 50% of private vehicle users switched to electric vehicles.
Results: The sample included 16 997 participants with a weighted total of 3 506 325 536 US health care trips. Of these trips, 52.0% were reported by female travelers, 80.1% were made in urban areas, and 19.9% were made in rural areas. These trips accounted for 84 057 963 340 miles, resulting in weighted annual estimated emissions of 35.7 megatons (Mt) (95% CI, 27.5-43.9 Mt) CO2e. Each mile traveled generated an estimated 424 g (95% CI, 418-428 g) CO2e. Emissions per trip were higher (exponentiated coefficient [exp(β)], 2.19; 95% CI, 1.51-2.86; P < .001) for rural patients compared with urban patients. However, 69.3% of emissions were attributable to urban patients and 30.7% to rural patients. Patients with annual median household incomes of $50 000 to $99 999 generated higher trip emissions (exp[β], 1.92; 95% CI, 1.09-2.76; P = .003) compared with those with incomes of $25 000 or less. A 30% shift to electric vehicles was estimated to reduce health care-related carbon emissions to 27.6 Mt (95% CI, 20.7-34.6 Mt) CO2e, and a 50% shift was estimated to lower emissions to 22.3 Mt (95% CI, 16.0-28.6 Mt) CO2e.
Conclusions And Relevance: This cross-sectional study estimated that annual patient health care-related travel in the US generated 35.7 Mt CO2e, which accounts for a small but important proportion of total health care-related emissions in the US. These findings are essential for informing health care policy decisions and suggest that strategies such as telehealth and the adoption of electric vehicles may contribute to a small but significant reduction in health care-related GHG emissions.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11959441 | PMC |
http://dx.doi.org/10.1001/jamanetworkopen.2025.2513 | DOI Listing |
J Gastrointest Surg
September 2025
Department of Upper Gastrointestinal and Hepatobiliary Surgery, Royal Prince Alfred Hospital, Sydney, Australia; RPA Institute of Academic Surgery, Sydney, Australia; School of Medicine, University of Sydney, Sydney, Australia; Surgical Outcomes Research Centre (SOuRCe), Sydney, Australia.
Background: 18F-fluorodeoxyglucose positron emission tomography (FDG-PET) is currently widely used in staging and re-staging oesophageal cancer after neoadjuvant therapy. The maximal standardized uptake value (SUVmax) is a reproducible parameter that may predict survival. This study aimed to determine the prognostic significance of SUVmax and the change in SUVmax after neoadjuvant treatment (ΔSUVmax) on overall and disease-free survival.
View Article and Find Full Text PDFCan J Cardiol
September 2025
Division of Cardiology, Hartford HealthCare Heart and Vascular Institute, Hartford, CT, USA. Electronic address:
Post-transplant rejection surveillance remains a cornerstone of heart transplant care. Although endomyocardial biopsy (EMB) has long been the gold standard for detecting rejection, its invasive nature, interobserver variability in histologic interpretation, and limitations in distinguishing between acute cellular rejection (ACR) and antibody-mediated rejection have prompted interest in noninvasive techniques. Traditional biomarkers- such as troponin, C-reactive protein, brain natriuretic peptide, and donor-specific antibodies- offer supplementary assessments of graft function but lack the specificity and sensitivity required to be standalone markers.
View Article and Find Full Text PDFCancer Immunol Immunother
September 2025
Department of Nuclear Medicine and Molecular Imaging, Lausanne University Hospital, CHUV/UNIL, 1011, Lausanne, Switzerland.
Background: Immunotherapy is a mainstay in the treatment of patients with advanced melanoma. Yet, resistance mechanisms exist, and tumour-associated macrophages (TAMs), particularly the M2-like phenotype, are associated with poorer outcomes, with CD206 serving as their specific marker. We present the first human SPECT/CT study to visualize CD206 + TAMs in patients undergoing immunotherapy and compare the findings to clinical outcomes (NCT04663126).
View Article and Find Full Text PDFEur J Nucl Med Mol Imaging
September 2025
Advanced Neuroimaging Center, Institute for Quantum Medical Science, National Institutes for Quantum Science and Technology, 4-9-1 Anagawa, Chiba-shi, Chiba, 263-8555, Japan.
Purpose: Astrocyte reactivation can be assessed using positron emission tomography (PET) ligands targeting monoamine oxidase B (MAO-B). C-SL25.1188 binds reversibly to MAO-B, allowing precise density measurements, but requires invasive arterial sampling.
View Article and Find Full Text PDFJACC Case Rep
September 2025
Barts Heart Centre, St Bartholomew's Hospital, Barts Health NHS Trust, London, United Kingdom; Newham University Hospital, Barts Health NHS Trust, London, United Kingdom. Electronic address:
Background: Myocarditis secondary to Listeria monocytogenes is rare but life-threatening.
Case Summary: A 54-year-old woman with a prior history of systemic lupus erythematous on immunosuppression presented with chest pain and fever. Troponin and C-reactive protein levels were elevated, and an electrocardiogram showed T-wave inversion.